Sao Tome and Principe vs Vanuatu: New or unknown treatment history cases: Pulmonary, bacteriologically
Sao Tome and Principe
55
in 2023
Vanuatu
59
in 2023
Sao Tome and Principe rank
168th
Vanuatu rank
167th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Sao Tome and Principe
- Vanuatu
How they compare
Vanuatu currently reports 59 against 55 in Sao Tome and Principe, a difference of 4.
That makes Vanuatu's figure about 1.1 times Sao Tome and Principe's.
The two have swapped places 7 times across 11 shared years of data; in 2013 it was Sao Tome and Principe ahead.
Sao Tome and Principe ranks 168th and Vanuatu ranks 167th of 197 countries.
Sao Tome and Principe has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Sao Tome and Principe | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.86 | 41.71 | 15.14 | Sao Tome and Principe |
| 2020s | 58 | 51.25 | 6.75 | Sao Tome and Principe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Sao Tome and Principe or Vanuatu?
- Vanuatu, at 59 against 55 in Sao Tome and Principe as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Sao Tome and Principe and Vanuatu?
- 4, with Vanuatu ahead.
- How many years of comparable data are there for Sao Tome and Principe and Vanuatu?
- 11 years are reported by both, from 2013 to 2023.
- How do Sao Tome and Principe and Vanuatu rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Sao Tome and Principe ranks 168th and Vanuatu ranks 167th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.